Perspectives
The Performance of Rest
Search interest in sleep optimization wearables, recovery scoring algorithms, circadian lighting systems, and digital insomnia therapeutics has accelerated across consumer...
Read more
The Loneliness of Precision
Search activity around precision oncology protocols, individualized metabolic regimens, pharmacogenomic decision tools, and personalized treatment algorithms has intensified across clinical...
Read more
Between Annual Checkups and Weekly Biomarkers
A decision about a peptide protocol rarely begins in a clinic. It begins in a search bar, a group chat,...
Read more
The Mirage of Perfect Personalization
Artificial intelligence and genomic sequencing have converged to make this proposition technically plausible. Algorithms trained on massive datasets now analyze...
Read more
The Patient as Consumer—and the Limits of the Metaphor
Healthcare consumerism—the idea that patients should compare prices, evaluate quality metrics, and choose providers the way they might choose airlines...
Read more
When Exhaustion Loses Its Prestige
Sleep deprivation, once a tacit credential in medicine, finance, and technology, is increasingly recast as risk rather than dedication. Accumulating...
Read more
The Hormone Reckoning
Now it is back—cautiously, strategically, and with far more data than when it was sent away. Interest in hormone replacement...
Read more
Questions to Ask Your Functional Medicine Provider
Remember these important questions to ask your functional medicine provider if you want to make the most out of your...
Read more
The best hobbies for people with anxiety issues.
Discover the best hobbies for people with anxiety issues, from creative projects to physical activities that reduce stress and help...
Read more
What To Ask Your Provider Before Home Oxygen Use
New prescriptions for home oxygen raise practical concerns. Understanding what to ask your provider before home oxygen use supports confident...
Read moreSexual Health Information Is Escaping the Clinic and Rewriting the Care Pathway
Sexual health has left the exam room, entered the search bar, and brought utilization patterns with it. Search and social...
Read more
Prevention Is Having a Moment and a Measurement Problem
The most expensive diseases in modern medicine are now being chased upstream by search engines, wearable sensors, and uneasy payment...
Read more
FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read more